3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
66
Lymphoma, Large B-Cell, Diffuse
48
Lymphoma
34
Burkitt Lymphoma
28
Lymphoma, Follicular
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Neoplasms
14
Lymphoma, Non-Hodgkin
14
Lymphoma, B-Cell
12
Lymphoma, T-Cell, Peripheral
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Hodgkin Disease
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia
8
Recurrence
6
Prostatic Neoplasms, Castration-Resistant
6
Multiple Myeloma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Neoplasm Metastasis
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Anaplastic
4
Immunoblastic Lymphadenopathy
4
Ovarian Neoplasms
3
Myasthenia Gravis
3
Metastatic Castration-resistant Prostate Cancer
3
Melanoma
3
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Prednisone
×
1 year
×
Clear all
No trials found.